✦ LIBER ✦

Complete response of a primary cutaneous T-cell-rich B cell lymphoma treated with interferon α2a

✍ Scribed by U. Wollina

Book ID: 118785522
Publisher: Springer-Verlag
Year: 1998
Tongue: English
Weight: 794 KB
Volume: 124
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s004320050144

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of pegylated interferon α-2b

Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma

✍ A.C. Hüsken; A. Tsianakas; P. Hensen; D. Nashan; C. Loquai; S. Beissert; T.A. Lu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Primary cutaneous B-cell lymphoma: treat

Primary cutaneous B-cell lymphoma: treatment with low dose intralesional recombinant inter-feron-α2a

✍ Pietro Rubegni; Giovambattista De Aloe; Elisa Pianigiani; Stefano Lazzi; Michele 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 827 KB

A case of syringotropic cutaneous T-cell

A case of syringotropic cutaneous T-cell lymphoma treated with local radiotherapy

✍ Rojymon Jacob; Matthew Scala; Maxwell A. Fung 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Treatment of Cutaneous T Cell Lymphoma S

Treatment of Cutaneous T Cell Lymphoma Stage II with Interferon-α-2a and Extracorporeal Photochemotherapy : A Prospective Controlled Trial

✍ U. WOLLINA; A. LOOKS; J. MEYER; B. KNOPF; H.-J. KOCH; K. LIEBOLD; U.-C. HIPLER 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Phase II trial of interferon-α-2a plus p

Phase II trial of interferon-α-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma

✍ Vanna Chiarion-Sileni; Antonio Bononi; Cleto Veller Fornasa; Mariella Soraru; Ma 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Purpose: To evaluate the efficacy and side effects of psolaren with ultraviolet light a (puva) and interferon-alpha-2a (ifn-alpha-2a) in patients with mycosis fungoides (mf) and sézary syndrome (ss). ## Patients and methods: From may 1993 to january 1999, 63 symptomatic patients with all stage

Durable loss of a malignant T-cell clone

Durable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon and photopheresis

✍ Heather R. Haley; Daniel A. Davis; W.Mitchell Sams 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 164 KB